ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,455.21
      0.38%
      US Tech 100
      18,530.80
      0.15%
      Dow Jones
      40,008.39
      0.61%
      Brent Oil
      79.62
      -1.21%
      Bitcoin
      58,859.45
      -2.90%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Emergent Biosolutions Inc (EBS)

      7. Emergent Biosolutions Inc (EBS) News

      EBS

      Emergent Biosolutions (EBS)

      Emergent Biosolutions Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:EBS
      DateTimeSourceHeadlineSymbolCompany
      08/06/20245:01PMGlobeNewswire Inc.Emergent BioSolutions Reports Second Quarter 2024 Financial ResultsNYSE:EBSEmergent Biosolutions Inc
      08/06/20244:34PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:EBSEmergent Biosolutions Inc
      08/06/20244:21PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      08/06/20248:00AMGlobeNewswire Inc.Emergent BioSolutions Expands NARCAN® Nasal Spray Distribution Capabilities to Enhance Customer Delivery Experience Across the CountryNYSE:EBSEmergent Biosolutions Inc
      07/31/20248:56AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      07/31/20248:53AMGlobeNewswire Inc.Emergent BioSolutions Completes Sale of RSDL® (Reactive Skin Decontamination Lotion) Kit to SERB Pharmaceuticals for $75 MillionNYSE:EBSEmergent Biosolutions Inc
      07/30/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      07/24/20247:30AMGlobeNewswire Inc.Emergent BioSolutions Launches Opioid Emergency Preparedness ‘Lay, Spray, Stay’ Public Education Campaign Starring Pro Football Hall of Famer Emmitt SmithNYSE:EBSEmergent Biosolutions Inc
      07/23/20248:27AMGlobeNewswire Inc.Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6, 2024NYSE:EBSEmergent Biosolutions Inc
      07/22/20248:00AMGlobeNewswire Inc.Emergent BioSolutions Announces Shelf-Life Extension for NARCAN® Nasal Spray in CanadaNYSE:EBSEmergent Biosolutions Inc
      07/12/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      07/12/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      07/10/20244:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      07/09/20247:30AMGlobeNewswire Inc.Emergent BioSolutions Continues to Drive Improved Financial Position as Part of Multi-Year Transformation PlanNYSE:EBSEmergent Biosolutions Inc
      07/08/20244:57PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      07/02/20249:43AMGlobeNewswire Inc.Update: Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure ProductsNYSE:EBSEmergent Biosolutions Inc
      07/02/20248:13AMGlobeNewswire Inc.Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure ProductsNYSE:EBSEmergent Biosolutions Inc
      06/20/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      06/20/20247:00AMGlobeNewswire Inc.Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 MillionNYSE:EBSEmergent Biosolutions Inc
      06/11/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      06/11/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      06/11/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      06/11/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      06/06/20244:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      06/06/20249:02AMGlobeNewswire Inc.Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness DayNYSE:EBSEmergent Biosolutions Inc
      06/04/20244:19PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:EBSEmergent Biosolutions Inc
      05/31/20243:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      05/29/20247:34AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
      05/28/20249:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
      05/28/20249:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
       Showing the most relevant articles for your search:NYSE:EBS